These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 16377516)
1. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. Rubbia-Brandt L; Mentha G; Terris B J Am Coll Surg; 2006 Jan; 202(1):199-200. PubMed ID: 16377516 [No Abstract] [Full Text] [Related]
2. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Morris-Stiff G; Tan YM; Vauthey JN Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887 [TBL] [Abstract][Full Text] [Related]
3. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month. Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961 [TBL] [Abstract][Full Text] [Related]
4. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Rubbia-Brandt L; Audard V; Sartoretti P; Roth AD; Brezault C; Le Charpentier M; Dousset B; Morel P; Soubrane O; Chaussade S; Mentha G; Terris B Ann Oncol; 2004 Mar; 15(3):460-6. PubMed ID: 14998849 [TBL] [Abstract][Full Text] [Related]
5. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638 [TBL] [Abstract][Full Text] [Related]
6. [Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases]. Gómez-Ramírez J; Martín-Pérez E; Amat CG; Sanz IG; Bermejo E; Rodríguez A; Larrañaga E Cir Esp; 2010 Dec; 88(6):404-12. PubMed ID: 20971458 [TBL] [Abstract][Full Text] [Related]
7. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. Khan AZ; Morris-Stiff G; Makuuchi M J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069 [TBL] [Abstract][Full Text] [Related]
9. Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity? Sebagh M; Plasse M; Lévi F; Adam R Ann Oncol; 2005 Feb; 16(2):331; author reply 332-3. PubMed ID: 15668292 [No Abstract] [Full Text] [Related]
10. Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. Seo AN; Kim H Clin Mol Hepatol; 2014 Mar; 20(1):81-4. PubMed ID: 24757663 [No Abstract] [Full Text] [Related]
11. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis. Stevenson HL; Prats MM; Sasatomi E BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766 [TBL] [Abstract][Full Text] [Related]
12. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448 [TBL] [Abstract][Full Text] [Related]
13. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811 [TBL] [Abstract][Full Text] [Related]
14. Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases. Han NY; Park BJ; Yang KS; Kim MJ; Sung DJ; Sim KC; Cho SB AJR Am J Roentgenol; 2017 Nov; 209(5):1039-1045. PubMed ID: 28813196 [TBL] [Abstract][Full Text] [Related]
15. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases. Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348 [TBL] [Abstract][Full Text] [Related]
16. [Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review]. Baumgaertner I; Ratziu V; Vaillant JC; Hannoun L; Poynard T; André T Bull Cancer; 2010 May; 97(5):559-69. PubMed ID: 20167564 [TBL] [Abstract][Full Text] [Related]
17. [Steatohepatitis after chemotherapy for colorectal liver metastases (CASH)]. Tannapfel A; Reinacher-Schick A; Flott-Rahmel B Pathologe; 2011 Jul; 32(4):330-5. PubMed ID: 21681471 [TBL] [Abstract][Full Text] [Related]
18. Preoperative assessment of chemotherapeutic associated liver injury based on indocyanine green retention test. Russolillo N; Langella S; Perotti S; Lo Tesoriere R; Forchino F; Ferrero A Int J Surg; 2016 Jul; 31():80-5. PubMed ID: 27260311 [TBL] [Abstract][Full Text] [Related]
19. Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases. Robinson SM; White SA Histopathology; 2012 Dec; 61(6):1247-8. PubMed ID: 23043422 [No Abstract] [Full Text] [Related]
20. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection. Duwe G; Knitter S; Pesthy S; Beierle AS; Bahra M; Schmelzle M; Schmuck RB; Lohneis P; Raschzok N; Öllinger R; Sinn M; Struecker B; Sauer IM; Pratschke J; Andreou A Eur J Surg Oncol; 2017 Sep; 43(9):1668-1681. PubMed ID: 28599872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]